Screening With Cognes for Earlier Detection of Alzheimer’s

Alzheimer’s disease affects millions of people around the world, and it is necessary to recognize it as early as possible. While people try to avoid the discomfort of current invasive methods and tests, it is essential to find less invasive methods.

Cognes makes use of a non-invasive method that can be conducted by yourself for early detection of this disease. It is also very important that Alzheimer’s disease be detected as early as possible to slow down the declining activities of the brain.

Let\’s take a closer look at this screening method that will help detect Alzheimer’s so treatment can start at an early stage.

How Will It Ensure Early Detection?

Existing tests and diagnostic methods to detect Alzheimer’s in patients are expensive and invasive, making it impractical to detect the disease early. The self-administration method developed by Cognes is a smartphone app that anyone can use to detect the disease.

This test is safe and completely non-invasive, with a simple measurement of the face and cerebral features that can be done quickly and easily. This means the app can be used to test on a daily basis to keep track of the changes that may occur over time.

As part of the app, the cognitive assessment tests are designed to be sensitive to early and specific symptoms of early Alzheimer’s disease. This will help allow the app to uncover the subtle differences between other types of dementia and the stages of Alzheimer’s disease.

With the ongoing screening that the app allows, you will be able to detect the disease much earlier than with existing methods and tests. Thus, treatment can begin much sooner and, in some cases, can be reversed if caught early enough for a much better life for the patient.

The Scalability of Cognes

Early detection of the disease will allow the patient to have a much longer and healthier life with early treatment. This makes the Cognes screening so much more effective because it can be used at a much younger age.

With the app becoming available to more people, it will be more effective, and everyone can use it to do the tests. This is great for those with little to no access to medical facilities will also be able to detect the disease much earlier.

If this test can be installed on every smartphone, you will have a much healthier society with meaningful lives, even for those with the disease. That will be because quality care for those people with the disease can be started early for better results.

The great thing about Cognes is that it can be used not just for Alzheimer’s but also for all other types of dementia. With the increase in deaths from Alzheimer’s of more than 140 percent, this method will be welcomed for early detection of the disease.

It Is Cost-Effective

The soaring prices of existing methods to diagnose a patient and detect the disease will change the financial impact drastically. At much lower costs, the app can be installed on smartphones, which will not just be affordable to them but can save the patients’ lives.

The early detection will positively impact the lives of the patient’s loved ones as well. This means they can start to save money at an early stage for the times when the disease gets worse and will cost more money.

It will also help to not deplete their medical insurance, and they will have access to better financial and medical facilities. This disease’s financial impact on the medical profession will also be more bearable.

It is very important that Alzheimer’s disease and other dementia be detected much earlier to help the patient plan ahead for better treatment. Early detection of the disease and better financial planning go hand in hand, leading to a better life for the patient and their loved ones.

Other Implications

When a patient is diagnosed with Alzheimer’s disease, it has a significant impact on the patient and their loved ones. Because the disease cannot be cured, many just do not want to accept the fact, which may cause stress for loved ones.

That is why it is important that the disease be detected very early so the patient and their families can adjust to the effects. While this method of screening is still in its early stages, it still makes remote screening possible for early diagnosis.

People will also be able to stay informed about the procedures for treatment to prevent the pitfall of negative rumors around Alzheimer’s. This is probably the most crucial part because news of this disease may sound like a death sentence to the patient and their loved ones.

It will also help misinformed people to have enough time to get the correct information about the disease and its effects. Many people think that with this disease, it will only be the loss of memory that the patient may experience.

The dangerous part of misinformation is the patients’ expectations versus reality, which do not match up. Early detection will help everyone involved, even their medical expert, prepare better for reality and what the patient should expect.

Another Positive Note

With early diagnoses of the disease, patients may have access to clinical trials to give them a better chance for recovery. So the earlier the disease is detected, the better chance a patient may have for a full and meaningful life.

While the disease is still in its early stages, participation in clinical trials may have a better impact on the condition and its causes.


Many people simply do not receive the tests to detect Alzheimer’s disease earlier because of the cost implications and the time used to do the tests. With Cognes, this will not be the case. You can have the test done in as little as 5 minutes and you will have the results almost immediately.


50-80% cases remain undiagnosed worldwide

Scroll to Top